Canadian Health Food Association presses for Bill C-51 amendments
The Canadian Health Food Association has launched a postcard lobby campaign to build on the group's recent advocacy efforts aimed at addressing members' concerns about a piece of legislation proposed in April by the federal government of Prime Minister Stephen Harper. Bill C-51 proposes amendments to the Food and Drugs Act, which has not been updated in 50 years.
"While [the] CHFA supports the government's commitment to ensuring Canadians are provided with foods and products that are safe and effective, our members cannot support legislation that categorizes natural health products as therapeutic products together with drugs and medical devices," said Penelope Marrett, the CHFA's president. She added that "this bill views NHPs through the lens of pharmaceutical drugs and that is just not right for consumers."
CHFA wants NHPs to be special category: neither food nor drugs
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze